Oxygen generating biomaterials at the forefront of regenerative medicine: advances in bone regeneration

Abstract

Globally, an annual count of more than two million bone transplants is conducted, with conventional treatments, including metallic implants and bone grafts, exhibiting certain limitations. In recent years, there have been significant advancements in the field of bone regeneration. Oxygen tension regulates cellular behavior, which in turn affects tissue regeneration through metabolic programming. Biomaterials with oxygen release capabilities enhance therapeutic effectiveness and reduce tissue damage from hypoxia. However, precise control over oxygen release is a significant technical challenge, despite its potential to support cellular viability and differentiation. The matrices often used to repair large-size bone defects do not supply enough oxygen to the stem cells being used in the regeneration process. Hypoxia-induced necrosis primarily occurs in the central regions of large matrices due to inadequate provision of oxygen and nutrients by the surrounding vasculature of the host tissues. Oxygen generating biomaterials (OGBs) are becoming increasingly significant in enhancing our capacity to facilitate the bone regeneration, thereby addressing the challenges posed by hypoxia or inadequate vascularization. Herein, we discussed the key role of oxygen in bone regeneration, various oxygen source materials and their mechanism of oxygen release, the fabrication techniques employed for oxygen-releasing matrices, and novel emerging approaches for oxygen delivery that hold promise for their potential application in the field of bone regeneration.

Advances in the Study of Extracellular Vesicles for Bone Regeneration

“…Globally, osteoporosis-related fractures occur at a rate of one every 20 s among individuals aged 50 and above, with over 2 million bone graft procedures conducted annually [ 1 ]. The extended healing duration associated with traditional treatments contributes significantly to the substantial healthcare expenses incurred and demonstrates certain inherent limitations [ 2 ]. The primary traditional treatment for bone defects is bone grafting, which can involve autologous bone, allogeneic bone, or synthetic materials [ 3 ].…”